![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CCDC144NL-AS1 |
Gene summary for CCDC144NL-AS1 |
![]() |
Gene information | Species | Human | Gene symbol | CCDC144NL-AS1 | Gene ID | 440416 |
Gene name | CCDC144NL antisense RNA 1 | |
Gene Alias | CCDC144NL-AS1 | |
Cytomap | 17p11.2 | |
Gene Type | ncRNA | GO ID | NA | UniProtAcc | NA |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
440416 | CCDC144NL-AS1 | P57T-E | Human | Esophagus | ESCC | 1.88e-04 | 1.38e-01 | 0.0926 |
440416 | CCDC144NL-AS1 | P61T-E | Human | Esophagus | ESCC | 3.11e-12 | 3.12e-01 | 0.099 |
440416 | CCDC144NL-AS1 | P74T-E | Human | Esophagus | ESCC | 3.81e-05 | 1.90e-01 | 0.1479 |
440416 | CCDC144NL-AS1 | P76T-E | Human | Esophagus | ESCC | 8.40e-04 | 1.71e-01 | 0.1207 |
440416 | CCDC144NL-AS1 | P79T-E | Human | Esophagus | ESCC | 3.41e-36 | 6.84e-01 | 0.1154 |
440416 | CCDC144NL-AS1 | P80T-E | Human | Esophagus | ESCC | 1.24e-27 | 6.73e-01 | 0.155 |
440416 | CCDC144NL-AS1 | P83T-E | Human | Esophagus | ESCC | 7.68e-17 | 4.10e-01 | 0.1738 |
440416 | CCDC144NL-AS1 | P107T-E | Human | Esophagus | ESCC | 4.70e-29 | 6.29e-01 | 0.171 |
440416 | CCDC144NL-AS1 | P126T-E | Human | Esophagus | ESCC | 3.18e-09 | 6.35e-01 | 0.1125 |
440416 | CCDC144NL-AS1 | P127T-E | Human | Esophagus | ESCC | 1.81e-06 | 1.82e-01 | 0.0826 |
440416 | CCDC144NL-AS1 | ATC09 | Human | Thyroid | ATC | 3.19e-31 | 9.60e-01 | 0.2871 |
440416 | CCDC144NL-AS1 | ATC13 | Human | Thyroid | ATC | 1.23e-94 | 1.51e+00 | 0.34 |
440416 | CCDC144NL-AS1 | ATC1 | Human | Thyroid | ATC | 2.76e-31 | 1.04e+00 | 0.2878 |
440416 | CCDC144NL-AS1 | ATC5 | Human | Thyroid | ATC | 7.34e-99 | 1.59e+00 | 0.34 |
Page: 1 2 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |